Boom Or Bust: What Is Next For Akebia Therapeutics Inc (NASDAQ: AKBA) Stock?
Akebia Therapeutics Inc (NASDAQ:AKBA)’s traded shares stood at 4.62 million during the last session, with the company’s beta value hitting 0.97. At the close of
Akebia Therapeutics Inc (NASDAQ:AKBA)’s traded shares stood at 4.62 million during the last session, with the company’s beta value hitting 0.97. At the close of
James Hardie Industries plc (NYSE:JHX)’s traded shares stood at 13.85 million during the last session, with the company’s beta value hitting 1.75. At the close
PTL Ltd (NASDAQ:PTLE)’s traded shares stood at 1.08 million during the last session. At the close of trading, the stock’s price was $0.27, to imply
Nuburu Inc (AMEX:BURU)’s traded shares stood at 7.35 million during the last session, with the company’s beta value hitting 0.40. At the close of trading,
Klotho Neurosciences Inc (NASDAQ:KLTO)’s traded shares stood at 5.61 million during the last session, with the company’s beta value hitting 2.58. At the close of
Top Wealth Group Holding Ltd (NASDAQ:TWG)’s traded shares stood at 1.63 million during the last session, with the company’s beta value hitting 0.71. At the
Twist Bioscience Corp (NASDAQ:TWST)’s traded shares stood at 1.16 million during the last session, with the company’s beta value hitting 2.38. At the close of
UroGen Pharma Ltd (NASDAQ:URGN)’s traded shares stood at 1.84 million during the last session, with the company’s beta value hitting 1.11. At the close of
Fly-E Group Inc (NASDAQ:FLYE)’s traded shares stood at 4.13 million during the last session, with the company’s beta value hitting -1.59. At the close of
Dow Inc (NYSE:DOW)’s traded shares stood at 14.1 million during the last session, with the company’s beta value hitting 0.86. At the close of trading,
© 2024, Powered by Smart TechOne